Combined treatment with galanthaminium bromide, a new cholinesterase inhibitor, and RS 67333, a partial agonist of 5-HT4 receptors, enhances place and object recognition in young adult and old rats

Progress in Neuro-Psychopharmacology and Biological Psychiatry

Volumn 27, Issue 1, 2003, Pages 185-195

  Lamirault, Laëtitia ^a   Guillou, Catherine ^a   Thal, Claude ^a   Simon, Hervé ^a  

^a CNRS   (France)

Author keywords

5 HT4 receptor agonist; Acetylcholinesterase inhibitor; Aging; Galanthaminium bromide; Rats; Recognition memory; RS 67333

Indexed keywords

1 (4 AMINO 5 CHLORO 2 METHOXYPHENYL) 3 (1 BUTYL 4 PIPERIDINYL) 1 PROPANONE; CHOLINESTERASE INHIBITOR; GALANTHAMINIUM BROMIDE; SEROTONIN 4 AGONIST; UNCLASSIFIED DRUG;

AGE; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; MALE; MEMORY CONSOLIDATION; NONHUMAN; PLACE PREFERENCE; RAT; RECOGNITION; TASK PERFORMANCE;

AGE FACTORS; ANILINE COMPOUNDS; ANIMALS; CHOLINESTERASE INHIBITORS; DRUG THERAPY, COMBINATION; GALANTAMINE; INJECTIONS, INTRAPERITONEAL; MALE; MEMORY; PATTERN RECOGNITION, AUTOMATED; PIPERIDINES; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN AGONISTS; TASK PERFORMANCE AND ANALYSIS;

EID: 0037304466     PISSN: 02785846     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0278-5846(02)00351-2     Document Type: Article

References (55)

1. Barnes C.A. Neurological and behavioral investigations of memory failure in aging animals. Int. J. Neurol. 21-22:1988;130-136.
2. Barnes C.A., McNaughton B.L. An age comparison of the rates of acquisition and forgetting of spatial information in relation to long-term enhancement of hippocampal synapses. J. Neurosci. 99:1985;1040-1048.
3. Bartus R.T., Dean R.L., Beer B., Lippa A.S. The cholinergic hypothesis of geriatric memory dysfunction: a critical review. Science. 217:1982;408-417.
4. Bierer L.M., Haroutunian V., Gabriel S., Knott P.J., Carlin L.S., Purohit D.P., Perl D.P., Schmeidler J., Kanof P., Davis K.L. Neurochemical correlates of dementia severity in Alzheimer' disease: relative importance of the cholinergic deficits. J. Neurochem. 64:1995;749-760.
5. Bliss T.V., Collingridge G.L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature. 361:1993;31-39.
6. Bussey T.J., Muir J.L., Aggleton J.P. Functionally dissociating aspects of event memory: the effects of combined perirhinal and postrhinal cortex lesions on object and place memory in the rat. J. Neurosci. 19:1999;495-502.
7. Cassel J.C., Jeltsch H. Serotoninergic modulation of cholinergic function in the central nervous system: cognitive implications. Neuroscience. 69:1995;1-41.
8. Chopin P., Briley M. Effects of four non-cholinergic cognitive enhancers in comparison with tacrine and galanthamine on scopolamine-induced amnesia in rats. Psychopharmacology. 106:1992;26-30.
9. Conrad C.D., Lupien S.J., Thanasoulis L.C., McEwen B.S. The effects of type I and type II corticosteroid receptor agonists on exploratory behavior and spatial memory in the Y-maze. Brain Res. 759:1997;76-83.
10. 4 receptor stimulation facilitates acetylcholine release in rat frontal cortex. NeuroReport. 5:1994;1230-1232.
11. Corey-Bloom J., Anand R., Veach J. A randomized trial evaluating the efficacy and safety of ENA 713 (rivastigmine tartrate), a new acetylcholinesterase inhibitor, in patients with mild to moderately severe Alzheimer's disease. Int. J. Geriatr. Psychopharmacol. 1:1998;55-65.
12. Court J.A., Perry E.K. CNS nicotinic receptors. Possible therapeutic targets in neurodegenerative disorders. CNS Drugs. 2:1994;216-233.
13. Cross A.J. Serotonin in Alzheimer-type dementia and other dementing illnesses. Whitaker-Azmitia P.M., Peroutka S.J. The Neuropharmacology of Serotonin. Ann. N.Y. Acad. Sci. vol. 600:1990;405-417.
14. Davies P., Maloney A.J.F. Selective loss of central cholinergic neurones in Alzheimer's disease. Lancet. ii:1976;1403.
15. Dellu F., Mayo W., Cherkaoui J., Le Moal M., Simon H. A two-trial memory task with automated recording: study in young and aged rats. Brain Res. 588:1992;132-139.
16. Dellu F., Fauchey V., Le Moal M., Simon H. Extension of a new two-trial memory task in the rat: influence of environmental context on recognition processes. Neurobiol. Learn. Mem. 67:1997;112-120.
17. 4 receptors. Trends Pharmacol. Sci. 16:1995;391-398.
18. 4) receptor ligands in rat spatial navigation. Neuropharmacology. 36:1997;689-696.
19. Grady C.L., Craik F.I.M. Changes in memory processing with age. Curr. Opin. Neurobiol. 10:2000;224-231.
20. Iliev A.I., Traykov V.B., Mantchev G.T., Stoykov I., Prodanov D., Yakimova K.S., Krushkov I.M. A post-ischaemic single administration of galanthamine, a cholinesterase inhibitor, improves learning ability in rats. J. Pharm. Pharmacol. 52:2000;1151-1156.
21. Kihara T., Shimohama S., Urushitani M., Sawada H., Kimura J., Kume T., Maeda T., Akaike A. Stimulation of alpha4beta2 nicotinic acetylcholine receptors inhibits beta-amyloid toxicity. Brain Res. 792:1998;331-334.
22. Kosasa T., Kuriya Y., Matsui K., Yamanishi Y. Inhibitory effects of donepezil hydrochloride (E2020) on cholinesterase activity in brain and peripheral tissues of young and aged rats. Eur. J. Pharmacol. 386:1999;7-13.
23. 4 receptors of long-term potentiation and depotentiation in the dentate gyrus of freely moving rats. Cereb. Cortex. 12:2002;150-162.
24. 4 receptors. Neuropharmacology. 41:2001;844-853.
25. Laurent B., Thomas-Anterion C., Allegri R.F. Memory and dementia. Rev. Neurol. (Paris). 154:1998;S33-S49.
26. Lelong V., Dauphin F., Boulouard M. RS 67333 and D-cycloserine accelerate learning acquisition in the rat. Neuropharmacology. 41:2001;517-522.
27. Lena I., Garbay C., Dauge V. Involvement of D2 dopamine receptors in the opposing effects of two CCK-B agonists in a spatial recognition memory task: role of the anterior nucleus accumbens. Psychopharmacology. 153:2001;170-179.
28. Maelicke A., Samochocki M., Jostock R., Fehrenbacher A., Ludwig J., Albuquerque E.X., Zerlin M. Allosteric sensitization of nicotinic receptors as a treatment strategy for Alzheimer's disease. Biol. Psychiatry. 49:2001;279-288.
29. 4 receptor agonists and antagonist on rat learning and memory. Neuropharmacology. 39:2000;2017-2027.
30. Marchi M., Raiteri M. Nicotinic autoreceptors mediating enhancement of acetylcholine release become operative in conditions of "impaired" cholinergic presynaptic function. J. Neurochem. 67:1996;1974-1981.
31. Mary A., Renko D.Z., Guillou C., Thal C. Potent acetylcholinesterase inhibitors: design, synthesis and structure-activity relationships of bis-interacting ligands in the galanthamine series. Bioorg. Med. Chem. 6:1998;1835-1850.
32. Mattson M.P., Cheng B., Culwell A.R., Esch F.S., Lieberburg I., Rydel R.E. Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein. Neuron. 10:1993;243-254.
33. Mayo W., Dellu F., Robel P., Cherkaoui J., Le Moal M., Baulieu E.E., Simon H. Infusion of neurosteroids into the nucleus basalis magnocellularis affects cognitive processes in the rat. Brain Res. 607:1993;324-328.
34. McGaugh J.L. Memory - a century of consolidation. Science. 287:2000;248-251.
35. McGeer E.G., McGeer P.L. Neurotransmitter metabolism in the aging brain. Terry R.D., Gershon S. Neurobiology of Aging. 1976;389-403 Raven, New York.
36. Meneses A. 5-HT system and cognition. Neurosci. Biobehav. Rev. 23:1999;1111-1125.
37. 4 receptor agonists and antagonists in learning. Pharmacol. Biochem. Behav. 56:1997;347-351.
38. Meziane H., Dodart J.-C., Mathis C., Little S., Clemens J., Paul S.M., Ungerer A. Memory-enhancing effects of secreted forms of the β-amyloid precursor protein in normal and amnestic mice. Proc. Natl. Acad. Sci. 95:1998;12683-12688.
39. Ormerod B.K., Beninger R.J. Water maze versus radial maze: differential performance of rats in a spatial delayed match-to-position task and response to scopolamine. Behav. Brain Res. 128:2002;139-152.
40. Paxinos G. The Rat Nervous System. Forebrain and Midbrain. vol. 1:1985;112-116 Academic Press, San Diego.
41. Perry E.K., Perry R.H., Blessed G., Tomlinson B.E. Necropsy evidence of central cholinergic deficits in senile dementia. Lancet. i:1977;189.
42. Raskind M.A., Peskind E.R., Wessel T., Yuan W. A 6-month randomized, placebo-controlled trial with a 6-month extension. The Galantamine USA-1 Study Group. Neurology. 54:2000;2261-2268.
43. Reinikainen K.J., Soininen H., Riekkinen P.J. Neurotransmitter changes in Alzheimer's disease: implications to diagnostics and therapy. J. Neurosci. Res. 27:1990;576-586.
44. 4 receptors in post mortem human brain tissue: distribution, pharmacology and effects of neurodegenerative diseases. Br. J. Pharmacol. 114:1995;993-998.
45. Robbins T.W., Everitt B.J. Arousal and attention. Gazzaniga M.S. The Cognitive Neurosciences. 1995;703-720 MIT Press, Cambridge, USA.
46. 4 receptor regulates secretion of non-amyloidogenic precursor protein. J. Biol. Chem. 276:2001;44881-44888.
47. Rogers S., Friedhoff L.T. Long-term efficacy and safety of donepezil in the treatment of Alzheimer's disease: an interim analysis of the results of a US multicentre open-label extension study. Eur. Neuropsychopharmacol. 8:1998;67-75.
48. Schrattenholz A., Pereira E.F.R., Roth U., Weber K.-H., Albuquerque A. Agonist responses of neuronal nicotinic acetylcholine receptors are potentiated by a novel class of allosterically acting ligands. Mol. Pharmacol. 49:1996;1-6.
49. Steckler T., Drinkenburg W.H.I.M., Sahgal A., Aggleton J.P. Recognition memory in rats: II. Neuroanatomical substrates. Prog. Neurobiol. 54:1998;313-332.
50. Sweeney J.E., Bachman E.S., Coyle J.T. Effects of different doses of galanthamine, a long-acting acetylcholinesterase inhibitor, on memory in mice. Psychopharmacology. 102:1990;191-200.
51. Thal C., Guillou C., Mary A., Renko D.Z., Potier P., Christen Y. Novel galanthamine derivatives, preparation method therefor, use thereof as drugs, and pharmaceutical compositions containing such derivatives. PCT E.U. Int. Appl. WO. 97(3):1996;987.
52. Wilkinson D., Murray J. Galantamine: a randomized, double-bind, dose comparison in patients with Alzheimer's disease. Int. J. Geriatr. Psychiatry. 16:2001;852-857.
53. Wilson R.S., Bacon L.D., Kramer R.L., Fox J.H., Kasniak A.W. Word frequency effect and recognition memory in dementia of the Alzheimer type. J. Clin. Neuropsychol. 5:1983;97-104.
54. Wilson F.A.W., Scalaidhe S.P.O., Goldman-Rakic P.S. Dissociation of object and spatial processing domains in primate prefrontal cortex. Science. 260:1993;1955-1958.
55. Woodruff-Pak D.S., Vogel R.W., Wenk G.L. Galantamine: effect on nicotinic receptor binding, acetylcholinesterase inhibition, and learning. Proc. Natl. Acad. Sci. 98:2001;2089-2094.